argenx SE (ARGNF)
Makes antibody drugs that reduce immune system attacks on muscles and blood cells.
$803.19-0.07%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+58.0%
The outlook
ARGNF is trading below both its 50- and 200-day moving averages, sitting roughly mid-range in its 52-week span. Analyst sentiment leans bearish, and the stock carries a trailing P/E of 30.6x. Today's price action is essentially flat.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range62% of the way from its 52-week low to high
Market cap
$49.95B
52-wk high
$960.58
52-wk low
$547.60
50-day avg
$875.75
200-day avg
$833.74
Trailing P/E
30.6